Lewy Body Dementia
Neurology·MeSH: Lewy Body Disease
4 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| AL050 | Alector, Inc. (ALEC) |
Phase 2(1)
| Drug | Company |
|---|---|
| ACP-204 | ACADIA PHARMACEUTICALS INC (ACAD) |
Phase 1(1)
| Drug | Company |
|---|---|
| ov350 | Ovid Therapeutics Inc. (OVID) |
Preclinical(1)
| Drug | Company |
|---|---|
| ADP050-ABC | Alector, Inc. (ALEC) |
Compare drugs
Frequently asked questions
How many drugs are in development for Lewy Body Dementia?
BioSniper tracks 4 drugs in development for Lewy Body Dementia across 3 companies.
How many clinical trials target Lewy Body Dementia?
There are 2 clinical trials targeting Lewy Body Dementia tracked by BioSniper.
Deep-dive into Lewy Body Dementia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis